This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP (dPEP-KE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04050540
Recruitment Status : Active, not recruiting
First Posted : August 8, 2019
Last Update Posted : August 9, 2023
Sponsor:
Collaborators:
Kenya Medical Research Institute
Kenya National AIDS & STI Control Programme
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Jared Baeten, University of Washington

Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the ClinicalTrials.gov Results Quality Control (QC) review process. Results information is submitted to ClinicalTrials.gov by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 30, 2022
Estimated Study Completion Date : June 30, 2024
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 16, 2023
January 8, 2024 Submission with QC Comments